CV Sciences (CVSI) EBIT Margin (2013 - 2026)

CV Sciences (CVSI) reported EBIT Margin of 9.95% for Q1 2026, down 1026.0% on a YoY basis from 1.07% in Q1 2025, and down 338.86% sequentially from 2.27% in Q4 2025.

CV Sciences (CVSI) EBIT Margin (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 14 years of EBIT Margin data on file, last reported at 9.95% in Q1 2026.

  • For the quarter ending Q1 2026, EBIT Margin fell 1026.0% year-over-year to 9.95%; the trailing twelve-month figure through Mar 2026 stood at 5.97% (up 421.0% YoY), and the FY2025 full-year result was 3.41%, up 1054.0% from the prior year.
  • EBIT Margin retreated to 9.95% in Q1 2026, from 2.27% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 138.91% in Q1 2023 to a low of 55.94% in Q2 2022.
  • A 5-year average of 10.04% and a median of 14.74% in 2024 frame the typical range for EBIT Margin.
  • Across the five-year window, EBIT Margin soared 17298 bps in 2023 and plunged 15440 bps in 2024, its largest moves.
  • Tracing CVSI's EBIT Margin over 5 years: stood at 54.92% in 2022, then soared by 57 bps to 23.39% in 2023, then rose by 29 bps to 16.63% in 2024, then jumped by 86 bps to 2.27% in 2025, then tumbled by 339 bps to 9.95% in 2026.
  • Business Quant data shows CVSI's EBIT Margin at 9.95% in Q1 2026, 2.27% in Q4 2025, and 8.45% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn -9.95%

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.95%
Dec 31, 2025 -2.27%
Sep 30, 2025 -8.45%
Jun 30, 2025 -3.62%
Mar 31, 2025 0.31%
Dec 31, 2024 -16.63%
Sep 30, 2024 -8.82%
Jun 30, 2024 -14.74%
Mar 31, 2024 -15.49%
Dec 31, 2023 -23.39%
Sep 30, 2023 -10.69%
Jun 30, 2023 -27.13%
Mar 31, 2023 138.91%
Dec 31, 2022 -54.92%
Sep 30, 2022 -23.78%
Jun 30, 2022 -55.94%
Mar 31, 2022 -34.07%
Dec 31, 2021 -177.96%
Sep 30, 2021 -58.35%
Jun 30, 2021 -68.45%